Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,937 | 10,798 | 13,859 | 23,099 | 14,917 |
| Marketable Securities | 26,811 | 26,865 | 31,021 | 26,864 | 43,632 |
| Receivables | 133 | 178 | 552 | 435 | 331 |
| Inventories | 1,073 | 1,266 | 1,464 | 1,550 | 1,665 |
| TOTAL | $32,292 | $40,103 | $48,219 | $53,699 | $62,141 |
| Non-Current Assets | |||||
| PPE Net | 2,761 | 2,984 | 3,055 | 3,183 | 3,036 |
| Investments And Advances | 294 | 784 | 628 | 702 | 773 |
| Intangibles | 26,101 | 26,177 | 26,252 | 26,328 | 26,404 |
| Other Non-Current Assets | 2,115 | 2,333 | 2,548 | 2,759 | 2,967 |
| TOTAL | $31,272 | $32,278 | $32,482 | $32,972 | $33,180 |
| Total Assets | $63,563 | $72,381 | $80,702 | $86,671 | $95,321 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,294 | 2,176 | 1,864 | 2,028 | 1,482 |
| Accrued Expenses | 2,562 | 1,826 | 1,505 | 1,325 | 2,173 |
| Other current liabilities | 503 | 838 | 838 | 751 | 892 |
| TOTAL | $7,316 | $5,798 | $5,305 | $5,270 | $5,748 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 41 | 61 | 221 | 307 | 362 |
| Other Non-Current Liabilities | 1,659 | 2,080 | 2,299 | 2,370 | 2,900 |
| TOTAL | $2,372 | $2,799 | $2,998 | $3,049 | $3,560 |
| Total Liabilities | $9,688 | $8,597 | $8,304 | $8,319 | $9,307 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,118 | 1,063 | 1,063 | 1,042 | 1,041 |
| Common Shares | 38 | 37 | 37 | 36 | 36 |
| Retained earnings | -33,478 | -22,010 | -12,313 | -4,714 | 4,598 |
| Other shareholders' equity | 843 | 833 | 795 | 651 | 571 |
| TOTAL | $53,875 | $63,784 | $72,398 | $78,353 | $86,014 |
| Total Liabilities And Equity | $63,563 | $72,381 | $80,702 | $86,671 | $95,321 |